Introduction
According to hemodynamic status and right ventricular (RV) function of patients, acute Pulmonary Embolism (APE) can be divided into massive, submassive or mild. Massive PE is associated with systemic hypotension or cardiogenic shock, while submassive PE has only RV dysfunction without hypotension, and mild PE has neither systemic hypotension nor RV dysfunction [1] .
RV dysfunction playing a crucial role in hemodynamic instability, as acute increase in right ventricular (RV) afterload leading to ventricular strain and dilatation that can proceed to ventricular failure with cardiac arrest and death if not treated at the proper time [2] .
In-hospital mortality rate of acute pulmonary embolism ranging from 5% or less to 25-50%, in mild and massive PE, while submissive PE associated mortality rate of 3-15% [3] .
In initially normotensive APE patients poor clinical outcome is considered if RV dysfunction associated with injury [4] or enlargement even in initially stable patients [5] .
Tricuspid Annular Plane Systolic Excursion (TAPSE) is one of global RV function parameters that describe apex-to-base shortening [6] . TAPSE can be measured easily by M-Mode echocardiography and showed excellent correlation with RVEF [7] .
The Pulmonary Embolism Severity Index (PESI) was designed by Aujesky et al. in 2005, which comprises 11 frequently available clinical parameters with variable prognostic power [8] . On the basis of the PESI score, each patient is classified into one of five classes (I-V), with 30-day mortality ranging from 1.1% to 24.5%. Patients in classes I (less than 65 points) and II (66-85 points) are considered as low-risk and classes III (86-105 points), class IV (106-125 points) -V more than 125 points) are at high-risk.
Although The PESI used as a clinical prognostic model for patients with APE is a well validated and highly reliable [9] there was no available follow up study comparing PESI and echocardiographic criteria for detection of in hospital mortality to our knowledge.
Aim of the study
Our aim from this study is to evaluate the prognostic value of Tricuspid Annular Plane Systolic Excursion (TAPSE) as simple echocardiographic parameter for prediction of in hospital mortality in relation to the Pulmonary Embolism Severity Index (PESI) clinical risk score.
Patients and methods
This study was carried out in Dallah hospital Riyadh -Saudi Arabia including 50 patients diagnosed with APE, from December 2015 to December 2016. APE was confirmed by contrastenhanced multidetector computed tomography or V/Q scan if CT pulmonary angiography is contraindicated.
Consent: the study was approved by institutional ethical committee, informed written consent was obtained from each patient including clause for using images and data for research purposes.
All patient admitted to our hospital with confirmed diagnosis of APE was enrolled in this study. The diagnosis of APE was confirmed by contrast-enhanced multidetector computed tomography or V/Q scan if CT pulmonary angiography is contraindicated.
All patients, underwent full medical history, physical examination, CT pulmonary angiography, Echocardiography, ECG and laboratory tests (D-Dimer, ABG, CBC, Kidney and liver function tests). PESI clinical risk score was assessed for all patient.
Exclusion criteria
Patients who received thrombolytic therapy before initial echocardiography study, with known cor plumonale, chronic thromboembolic disease and patients died with 24 h of admission or patients refused enrollment in the study were excluded.
Those patients classified into three groups, Group I (20 patients) hemodynamically unstable (blood pressure <90 mmHg and/or Cardiogenic shock), Group II (15 patients) hemodynamically stable with RV dysfunction and Group III (15 patients) hemodynamically stable with normal RV function. For all included patients daily follow up was done with special consideration to parameters of PESI risk score and results were calculated and recorded in the 1st day, 3rd day of admission and 3rd PESI score calculated at day 7 of admission.
PESI clinical risk score calculation
Age per years, Male Sex (+10), History of Cancer (+30), History of Heart Failure (+10), Chronic Lung Disease (+10), Pulse !110 bpm (+20), Systolic B.P <100 mmHg (+30), Respiratory Rate !30 RR/min (+20), Temperature <36°C (+20), Altered mental status, ⁄ (+60), Arterial oxygen saturation <90% (+20) ⁄ (disorientation, lethargy, stupor or coma).
Echocardiography
Transthoracic echocardiography to do routine assessment of RVD was done and interpreted according to a standardized protocol by experienced physician using an Echocardiography system (GE Medical Systems, Vivid 7, Norway), as soon as possible after admission. All examinations were recorded digitally. In the parasternal long-axis view both RV and LV diastolic diameters were measured. LV and RV diastolic diameters were measured in the apical 4-chamber view, during late diastole at the level of the mitral and tricuspid valve tips (defined by the electrocardiogram R-wave), EF of the left ventricular was done by Simpson's method. At peak systole (defined as the end of the T wave in the ECG) and in apical four chamber view by placement of M-mode cursor in the tricuspid annulus, TAPSE is the amount of longitudinal motion of the tricuspid annulus [10] .
Echocardiography study was performed in the 1st day, 3rd and 7th day of admission.
PE treatment
Group I 13 patients received thrombolytic therapy, 4 refused the lytic therapy and three patients with contraindications to lytic therapy referred for surgical embolectomy.
Group II and group III patients in addition to the 4 patients who refused lytic therapy from group I were treated with subcutaneous low molecular weight heparin or I.V heparin infusion.
During Hospital course the condition of 4 patients from group II deteriorate and showed signs of haemodynamic instability which necessitate thrombolytic therapy administration.
Surgical embolectomy
Three cases from Group I were transferred for surgical embolectomy according to guidelines on emergency bases.
Surgical embolectomy was indicated according to American Heart Association (AHA) guideline which included a central or para-central (sub) massive embolism with one of the following situations: cardio-respiratory arrest, thrombus in the right heart, large patent foramen ovale (PFO), failure to respond to thrombolytic therapy, and absolute contraindications for thrombolytic therapy [11] (see Fig. 1 ).
Operative data
CT angiography showed central pulmonary embolism with large thrombus and there were extension in the right pulmonary artery in two of them, the third case had saddle shaped thrombus (Fig. 2) . Under general anesthesia median sternotomy were done, on pump surgery were done, through aorto-bicaval cannulation and Antegrade cardioplegia to the aortic root. Snaring of both superior and inferior vena cavea. Longitudinal arteriotomy incision to the main pulmonary were done extending to the bifurcation of its two branches and removal of the thrombus then milking of the peripheral part toward the main PA after passing and withdrawal of Fogerty catheter (Fig. 3 ).
Statistical analysis
SPSS version 22 was used for analyses. Shapiro-Wilk test was used for normality. Analysis of variance and Mann-Whitney tests (continuous variables) or v 2 and Fisher's exact tests (categorical variables) were used to test for statistically significant differences across levels of TAPSE, PESI, PAP, RV/LV, Age, BMI, BP and DDimer in descriptive analyses. Stepwise logistic regression models were used to identify predictors of mortality. A two-sided p < 0.05 was retained for statistical significance.
The strength and direction of relationships between TAPSE and measures of ventricular function were analyzed using Spearman's rank correlation coefficient.
A receiver operating characteristic (ROC) curve was used to assess the accuracy of TAPSE and PESI for mortality prediction. The optimum cutoff point was the point closest to the top lefthand corner on the ROC curve.
Results
Comparison between the three studied group as regard the demographic, clinical, echocardiographic and treatment option showed the mean age was 44.35 ± 10.8 years in group I, 46.2 ± 16.3 years in group II and 47.46 ± 17.26 years in group III. Females represent 60%, 60% and 53% in group I, II and III respectively. The mean BMI was 34.04 ± 4.24, 31.46 ± 4.24 and 30.6 ± 4.7 in group I, II and III respectively. Postoperative PE represent 25%, 40% and 27% of group I, II and III respectively. The mean value of D-Dimer was 7.79 ± 4.7 in group I, 6.96 ± 4.6 in group II and 3.42 ± 2.53 in group III, the mean value of systolic Blood pressure (B.P) was 71.4 ± 17.5 mmHg in group I, 103.6 ± 10.01 mmHg in Group II and 128.06 ± 9.1 mmHg in Group III. The mean value of PESI score was 130.95 ± 22.05 in group I, 103 ± 25.29 in group II and 75.46 ± 21.18 in group III. The mean systolic PA was 61.15 ± 11.08 mmHg in group I and 46.36 ± 13.6 mmHg in Group II and systolic PAP cannot be measured in group III due to absence of tricuspid regurgitation.
The mean RV/LV ratio was 1.17 ± 0.22, 0.91 ± 0.16 and 0.5 ± 0.06 in group I, II and III respectively. The mean value of TAPSE was 13.8 ± 2.02 mm in group I, 15.37 ± 1.7 mm in Group II and 19.67 ± 1.66 mm in Group III. 13 patients (65%) in group I received lytic therapy and 4 patients received lytic therapy in group II while no patients received lytic therapy in group III.
Death rate was 20% in Group I (4patients) Vs 13% in Group II (2 patients) while no death encountered in Group III.
As regard this comparison there was no statistically significant difference between the three groups as regard Age, Sex, BMI, Ddimer and post-operative presentation while there was statistically significant difference between the three groups as regard TAPSE, PESI, systolic Blood pressure and RV/LV ratio in (Table 1) .
Correlation was done between the measured TAPSE and PESI, systolic PAP, RV/LV ratio and systolic blood pressure in the three follow up days showed strong negative correlation with PESI, systolic PAP and RV/LV ratio while there was strong positive correlation with systolic blood pressure in (Table 2) .
Linear regression analysis done between TAPSE and PESI showed near symmetrical distribution of points around the line which indicates very strong negative correlation between TAPSE and PESI in (Fig. 4) .
Correlation was done between the measured PESI with systolic PAP, RV/LV ratio and systolic blood pressure in the three follow up days showed strong positive correlation with, systolic PAP and RV/ LV ratio while there was strong negative correlation with systolic blood pressure in (Table 3) .
As regard measured TAPSE patients divided into two subgroup; subgroup I TAPSE 14 mm (the mean TAPSE value was 17.32 ± 2.40 mm) and subgroup II TAPSE >14 mm (the mean TAPSE value was 12.45 ± 1.27 mm) and comparison was done between those subgroups and different studied parameters. We found that there was statistically significant difference between both subgroups as regard BMI, Lytic therapy, Embolectomy, systolic B.P, death rate and PESI, also we found same significant difference with all echocardiographic parameters (TAPSE, systolic PAP, RV/LV ratio) while there was no statistically significant difference between both subgroups as regard Age and D-Dimer in (Table 4) .
Comparison was done between mean values of TAPSE and PESI during follow up days in survivors and non survivors and showed that there was highly statistically significant difference and this difference is consistent during follow up days in (Table 5) . 
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The total mortality of our studied group was 6 patient all of them showed TAPSE value in the 1st day 14 mm and also all of them showed PESI score in the 1st value >124 points (Table 6 ).
Receiver operating characteristic (ROC) curve analysis of TAPSE determine that 14 mm was the optimal cutoff value when only PE related mortality is considered with under the curve (AUC) 0.994, p < 0.001 in Fig. 5 .
Receiver operating characteristic (ROC) curve analysis of PESI determine that 124 points was the optimal cutoff value when only PE related mortality is considered with under the curve (AUC) 0.983, p < 0.001 in Fig. 6 .
Discussion
Acute Pulmonary embolism is one of most common causes of sudden death, APE due to obstruction of pulmonary vasculature.
The treatment of APE depend of the Haemodynamic state of the patients with general agreement to give thrombolytic therapy or to do embolectomy if the patient is haemodynamically unstable while if the patient stable even if there is RV dysfunction (submassive) there is still controversy for thrombolytic therapy in this condition [12] , we did this study to search for predictor of mortality during hospital course which can help us in treatment decision in this situation. The American College of Chest Physicians guidelines [12] and the European Society of Cardiology emphasize the value of detecting RV dysfunction and measurement of cardiac biomarkers in risk stratification of acute PE and this will allow the identification of high-risk patients before they deteriorate clinically [1, 12] . The other method is the use of clinical risk prediction scores, such as PESI [13] .
Although TAPSE is a measure of RV longitudinal function, TAPSE <16 mm indicates RV systolic dysfunction, it has shown good correlation with other methods of global RV systolic function measurements, such as radionuclide-derived RV EF, 2D RV FAC (Fractional area change), 2D RVEF [14] . The RV longitudinal myocardial shortening is a significant contributor to RV function, more than the reduction in RV cavity diameter, as is the case for the LV function [10] .
In spite of presence of other study using PESI and TAPSE as prognostic markers in APE, frequent follow up with TAPSE and PESI for detection of in-hospital mortality was not studied in previous researches and so we studied this bedside simple echocardiography parameter in comparison to the well know PESI clinical risk score for prediction of prognosis in APE patients.
Our studied groups were matched as regard the age, sex, BMI, postoperative presentation and D-Dimer serum level without statistically significant difference.
In our study in 1st day, 3rd, 7th days of hospital admission we correlate measured TAPSE with PESI risk score, systolic PAP, systolic B.P and RV/LV diameter ratio.
We found there was significant negative correlation with PESI, PAP, RV/LV diameter and positive correlation with systolic B.P in the 1st day and this correlation was persistent through the 3rd and 7th days. This relation between TAPSE and RV dysfunction was proven in study by Satu et al. 2012 who found that TAPSE has the strongest correlation with RV ejection fraction detected by Cardiac MRI [15] . In another study by Vitarelli et al. 2014 there was positive significant correlation between PESI as a risk score and RV longitudinal strain which is a sophisticated echocardiography parameter in contrary to our simple TAPSE echocardiography parameter [16] . Our study showed consistent statistically significant difference between survivors and non survivors as regard both parameters TAPSE and PESI in the three days of follow up measurement and this can give us indicator of the importance of those parameters in follow up during hospital course and their role as accurate predictor of mortality, our finding was concluded also by Zhou et al. 2014 in meta-analysis which identified TAPSE and PESI has discriminative power to predict the short term death [9] .
In current study we analyzed ROC curve for both TAPSE and PESI for prediction of mortality and we found that AUC of TAPSE 0.994 p < 0.001 and AUC of PESI 0.983 p < 0.001, both parameters has excellent accuracy in mortality prediction according to Jones and Athanasiou 2005, they considered AUC !0.97 is excellent accuracy [17] .
It can be considered that both TAPSE and PESI are good predictors of mortality based on AUC excellent results, PESI has the advantage of being simple clinical score can be calculated from daily patient data also TAPSE is accurate and simple echocardiography method for detection of RV systolic dysfunction.
As regard TAPSE our excellent accuracy results are better than Pruszczyk, et al., 2014; they found by multivariable analysis that TAPSE is the only significant predictor for mortality with ROC analysis (AUC: 0.91, p < 0.0001) with good accuracy, this difference in accuracy due to patients included in their study were only normotensive patient while our study ranging from cardiogenic shock to hemodynamically stable patients also the percentage of mortality in his study was 3% while in our study the mortality rate was 12% [18] .
As regard PESI score excellent accuracy in our results are better than data found in meta-analysis done by Zhou et al. 2012 ; they found good accuracy of PESI in detection of APE mortality with AUC ranging between 0.75 and 0.92, this difference can be explained by our prospective nature of study design and its lower patient volume [9] .
In our study optimal point for TAPSE was 14 mm which has high sensitivity and specificity in mortality prediction, Pruszczyk et al., 2014 found in their study optimal point was 15 [18] while Lopo et al. 2014 [19] ; in their the optimal point was 16, this minor difference due to the nature of included patient for both studied they included hemodynamically stable patients only but our studied patients are mixed.
Also Lobo et al. [19] conducted a study on more than 700 patients with APE examining parameters of RV function, they confirm TAPSE <1.6 cm as a prognostic marker for death in this patient population.
In medical patients with pulmonary hypertension Forfia et al. 2006 [20] ; demonstrated that a TAPSE <18 mm was associated with fourfold increase in mortality after a 19 month follow up period.
In our study we can confirm the prognostic value of TAPSE 14 mm and those patients are more likely to die during hospital admission than patients with TAPSE 16 mm, Patients who had TAPSE 14 mm in the 1st study day showed statistically significant difference compared to patients with TAPSE >14 mm as regard BMI, Bl.p, systolic PAP, RV/LV diameter, PESI, Lytic therapy, embolectomy and death rate, these finding was in concordance with Lobo et al. 2014 [19] ; they found the same result at optimal point TAPSE 16 mm.
When we compared survived and non-survived patient we found statistically significant difference as regard TAPSE and PESI in the three follow up reading with minor decrease in significance of PESI in the 7th day and this can be explained by multiple factors usually used in PESI calculation while TAPSE significance was more consistent as single parameter.
As regard prediction of overall all mortality in APE, the values of TAPSE 14 mm or PESI !124 points has significance predictor power.
Conclusion
TAPSE and PESI can be used as a good prognostic tool for follow up patients with acute pulmonary embolism during hospital course and TAPSE has higher accuracy than PESI in mortality prediction. The routine use of TAPSE value 14 mm can be used as an important parameter in judgment of thrombolytic therapy decision in hemodynamically stable APE patients.
Limitations
Our study is a single center study with a small number of patients, which may limit the generalizability of these findings, future multi-center studies are needed to validate these findings.
